エーザイの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/10/09 | 11,050 | 11,195 | 10,675 | 10,710 | -200 | -1.8% | 1,051,900 |
2018/10/05 | 11,055 | 11,060 | 10,875 | 10,910 | -125 | -1.1% | 910,600 |
2018/10/04 | 11,275 | 11,275 | 10,990 | 11,035 | -215 | -1.9% | 914,600 |
2018/10/03 | 11,275 | 11,320 | 11,165 | 11,250 | -35 | -0.3% | 709,800 |
2018/10/02 | 11,200 | 11,295 | 11,125 | 11,285 | +140 | +1.3% | 1,209,500 |
2018/10/01 | 11,100 | 11,235 | 11,050 | 11,145 | +85 | +0.8% | 860,100 |
2018/09/28 | 10,930 | 11,180 | 10,910 | 11,060 | +240 | +2.2% | 1,361,900 |
2018/09/27 | 10,690 | 10,995 | 10,630 | 10,820 | +90 | +0.8% | 1,136,400 |
2018/09/26 | 10,610 | 10,845 | 10,565 | 10,730 | +85 | +0.8% | 951,400 |
2018/09/25 | 10,395 | 10,695 | 10,355 | 10,645 | +375 | +3.7% | 1,308,300 |
2018/09/21 | 10,590 | 10,660 | 10,200 | 10,270 | -330 | -3.1% | 1,852,700 |
2018/09/20 | 10,590 | 10,830 | 10,555 | 10,600 | +55 | +0.5% | 1,080,900 |
2018/09/19 | 10,680 | 10,735 | 10,440 | 10,545 | -110 | -1% | 1,087,700 |
2018/09/18 | 10,405 | 10,715 | 10,400 | 10,655 | +325 | +3.1% | 894,500 |
2018/09/14 | 10,580 | 10,585 | 10,235 | 10,330 | -165 | -1.6% | 1,601,700 |
2018/09/13 | 10,370 | 10,525 | 10,335 | 10,495 | +240 | +2.3% | 720,800 |
2018/09/12 | 10,335 | 10,340 | 10,150 | 10,255 | -160 | -1.5% | 733,700 |
2018/09/11 | 10,150 | 10,555 | 10,145 | 10,415 | +265 | +2.6% | 1,222,700 |
2018/09/10 | 9,871 | 10,170 | 9,869 | 10,150 | +262 | +2.6% | 784,900 |
2018/09/07 | 9,866 | 9,929 | 9,812 | 9,888 | +22 | +0.2% | 720,300 |
2018/09/06 | 9,899 | 9,908 | 9,727 | 9,866 | +59 | +0.6% | 893,400 |
2018/09/05 | 9,945 | 9,949 | 9,795 | 9,807 | -68 | -0.7% | 1,068,000 |
2018/09/04 | 10,000 | 10,015 | 9,812 | 9,875 | -68 | -0.7% | 667,100 |
2018/09/03 | 9,958 | 9,985 | 9,876 | 9,943 | -117 | -1.2% | 640,900 |
2018/08/31 | 9,869 | 10,080 | 9,785 | 10,060 | +240 | +2.4% | 1,236,600 |
2018/08/30 | 9,880 | 9,935 | 9,802 | 9,820 | +56 | +0.6% | 1,016,600 |
2018/08/29 | 9,775 | 9,830 | 9,737 | 9,764 | +21 | +0.2% | 725,200 |
2018/08/28 | 9,831 | 9,865 | 9,743 | 9,743 | -50 | -0.5% | 991,500 |
2018/08/27 | 9,962 | 9,980 | 9,782 | 9,793 | -146 | -1.5% | 1,042,700 |
2018/08/24 | 9,880 | 9,972 | 9,793 | 9,939 | +264 | +2.7% | 1,131,100 |
2018/08/23 | 9,740 | 9,757 | 9,646 | 9,675 | +15 | +0.2% | 616,600 |
2018/08/22 | 9,759 | 9,812 | 9,622 | 9,660 | -100 | -1% | 667,500 |
2018/08/21 | 9,556 | 9,774 | 9,480 | 9,760 | +152 | +1.6% | 1,200,200 |
2018/08/20 | 9,713 | 9,820 | 9,576 | 9,608 | +39 | +0.4% | 815,300 |
2018/08/17 | 9,870 | 9,879 | 9,551 | 9,569 | -166 | -1.7% | 1,022,500 |
2018/08/16 | 9,736 | 9,883 | 9,692 | 9,735 | -19 | -0.2% | 1,180,100 |
2018/08/15 | 9,635 | 9,773 | 9,604 | 9,754 | +47 | +0.5% | 630,400 |
2018/08/14 | 9,629 | 9,726 | 9,606 | 9,707 | +233 | +2.5% | 847,100 |
2018/08/13 | 9,510 | 9,652 | 9,466 | 9,474 | -121 | -1.3% | 1,035,900 |
2018/08/10 | 9,755 | 9,760 | 9,590 | 9,595 | -165 | -1.7% | 1,366,600 |
2018/08/09 | 9,792 | 9,874 | 9,713 | 9,760 | -41 | -0.4% | 666,000 |
2018/08/08 | 9,916 | 10,065 | 9,791 | 9,801 | -113 | -1.1% | 914,900 |
2018/08/07 | 9,810 | 10,025 | 9,766 | 9,914 | +70 | +0.7% | 907,200 |
2018/08/06 | 9,881 | 9,935 | 9,752 | 9,844 | -37 | -0.4% | 698,900 |
2018/08/03 | 9,887 | 9,950 | 9,814 | 9,881 | +38 | +0.4% | 931,100 |
2018/08/02 | 9,900 | 10,035 | 9,810 | 9,843 | +17 | +0.2% | 1,720,100 |
2018/08/01 | 9,678 | 9,859 | 9,571 | 9,826 | +244 | +2.5% | 1,720,300 |
2018/07/31 | 9,480 | 9,630 | 9,330 | 9,582 | -74 | -0.8% | 2,923,500 |
2018/07/30 | 9,895 | 9,997 | 9,639 | 9,656 | -544 | -5.3% | 2,329,900 |
2018/07/27 | 9,945 | 10,355 | 9,857 | 10,200 | +211 | +2.1% | 3,897,900 |
1601~
1650
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
エーザイ | 427,100円 | +1.7% | -2.9% | 3.75% | 28.02倍 | 1.47倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 245,700円 | +5.7% | +3.9% | 2.50% | 12.22倍 | 1.62倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
協和キリン | 219,100円 | -3.5% | -11.3% | 2.74% | 20.12倍 | 1.35倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
小野薬 | 166,700円 | -3.1% | -63.4% | 4.80% | 15.66倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム